Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2010; Volume 198, Supplement 677
Joint Meeting of the Scandinavian and German Physiological Societies
3/27/2010-3/30/2010
Copenhagen, Denmark


INHIBITION OF SHP-2 IMPAIRS VEGF DEPENDENT ANGIOGENIC PROCESSES BY REGULATION OF VEGFR-2 EXPRESSION
Abstract number: P-MON-19

MANNELL1 H, SCHILBERG1 K, SOHN1 HY, POHL1 U, KROETZ1 F

Aims: Hypoxia/reoxygenation (H/R) triggers the release of the potent angiogenic stimulus vascular endothelial growth factor (VEGF) and of reactive oxygen species (ROS). The tyrosine phosphatase SHP-2 is activated by growth factors (GF), but it is unknown whether it is involved in H/R dependent angiogenesis and ROS generation. We investigated whether SHP-2 has a role in VEGF dependent ROS production and angiogenesis signalling in human endothelial cells (EC). Methods: SHP-2 activity in human microvascular endothelial cells (HMEC) was inhibited by SHP-2 siRNA magnetofection or application of the pharmacological inhibitor PtpI IV. SHP-2 activity was measured by the ability to dephosphorylate pNPP, its membrane recruitment was detected by cell fractioning and immunoblotting of the different fractions. Tyrosine phosphorylation of SHP-2 and Akt activation was assessed by Western blotting. Expression of VEGFRs was measured by FACS. Super oxide formation was determined by measuring cytochrome c reduction Results: One hour of hypoxia followed by one hour of reoxygenation (p<0.05, n=6) was associated with enhanced SHP-2 activity (p<0.05, n=7) and ROS production in HMEC. VEGF (50ng/ml, 10min) enhanced SHP-2 phosphatase activity (p<0.05, n=11) as well as membrane translocation (p<0.05, n=4) and phosphorylation of its tyrosine residues (p<0.05, n=3). Knock-down of SHP-2 by siRNA (50nM) prohibited VEGF dependent Akt activation (n=3) and inhibition of SHP-2 by PtpI IV application (2mM) impaired VEGF dependent formation of capillary like structures by 82±5% (p<0.01, n=2). As shown by western blotting and FACS both VEGFR-1 and -2 were naturally expressed on HMEC (p<0.001, n=3). Interestingly, SHP-2 did not bind to the VEGFR-2 upon VEGF stimulation (n=3) but SHP-2 siRNA significantly reduced the expression of VEGFR-2 at the cell surface (p<0.01, n=6). Conclusions: Our results indicate that SHP-2 is an essential signalling intermediate for VEGF dependent EC signalling and tube formation via regulation of Akt activity and VEGFR-2 expression.

To cite this abstract, please use the following information:
Acta Physiologica 2010; Volume 198, Supplement 677 :P-MON-19

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE